Abstract: An oyster peptide with an effect of improving sexual function and a preparation method thereof are provided, the oyster peptide at least includes peptide segments RI, IR and VR in its composition. Based on a mass of the oyster peptide, a content of the RI is ?3.60 mg/100 g, a content of the IR is ?7.60 mg/100 g, and a content of the VR is ?6.50 mg/100 g.

Abstract: Provided are fusion molecule having a PD-L1 inhibitor fused to a human IL-7 protein or fragment thereof through a peptide linker. The disclosed fusion molecules exhibited synergistic anti-tumor effects.

Abstract: Methods for preparation of a carbon membrane include providing a solution comprising a diacetyl biphenyl monomer and an alkylsulfonic acid. The solution is treated under such conditions that an aldol condensation reaction occurs so as to produce a porous polymer network. The porous polymer network is treated under such conditions that a Scholl reaction occurs.

Abstract: The present disclosure provides a data transmission method and a data transmission device for an intelligent driving vehicle, and a device. The method includes: acquiring data to be transmitted; encoding the data to be transmitted to generate encoded data; generating a check digit according to the data to be transmitted; adding the encoded data to a data packet, wherein a trailer of the data packet comprises the check digit; and transmitting the data packet.

Abstract: Provided are a communication system and a communication method of an autonomous vehicle. The system includes: a plurality of application modules, and an in-vehicle terminal. The in-vehicle terminal includes: an external communication module configured to communicate with another autonomous vehicle or a server in a message mode, and an internal communication module configured to communicate with the plurality of application modules in a service mode.

Abstract: Provided are anti-PD-L1 antibodies or fragments thereof. The antibodies or fragments thereof specifically bind to the immunoglobulin C domain of the PD-L1 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 116, a VH CDR3 of SEQ ID NO: 117, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.

Abstract: Provided are polypeptides having an antigen-binding unit targeting a tumor antigen and an IL-7 protein or fragment thereof, fused to a Fc fragment. The disclosed polypeptides can be used for treating cancer.

Abstract: Provided are bispecific and multi-specific antibodies that target both claudin 18.2 (CLDN18.2) and 4-1BB. These antibodies, in the absence of CLDN18.2-expressing cells, can bind to 4-1BB but are unable to activate 4-1BB signaling. In the presence of CLDN18.2-expressing cells, however, these antibodies can trigger CLDN18.2-dependent 4-1BB signaling, leading to potent immune response to the CLDN18.2-expressing tumor cells.

Abstract: The present disclosure provides an anti-PD-L1/anti-4-1BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1BB and its ligand. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1BB protein.

Abstract: Provided are anti-PD-L1 antibodies or fragments thereof. The antibodies or fragments thereof specifically bind to the immunoglobulin C domain of the PD-L1 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 116, a VH CDR3 of SEQ ID NO: 117, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.

Abstract: A dimming track lamp has a detachable assembly housing with a power supply track, a control circuit board electrically connected with the power supply track, a lamp body arranged on the assembly housing, a printed circuit board arranged in the lamp body, a light source on the printed circuit board and an optical element arranged in the light output direction of the light source. The control circuit board has a power supply module which is electrically connected with the power supply track, a signal input module, a signal processing module for analyzing and calculating the input signal and generating a control signal, and a signal output module for outputting the control signal to the printed circuit board. The light source has a warm light source and a cold light source, the control signal is used to control the light output of the warm light source and the cold light source.

Abstract: Provided is a smart roadside unit, including: a high-bright camera assembly configured to capture a high-bright image; a low-bright camera assembly configured to capture a low-bright image, in which the high-bright camera assembly and the low-bright camera assembly have a substantially same shooting view; and a controller configured to extract vehicle information from the high-bright image and the low-bright image.

Abstract: A curable organopolysiloxane composition is provided. The curable organopolysiloxane composition comprises: (A) a diorganopolysiloxane having at least two silicon-bonded alkenyl groups per molecule; (B) an organopolysiloxane resin; (C) a mixture of (C1) a diorganopolysiloxane endblocked with silicon-atom bonded hydrogen atoms at both molecular terminals and (C2) an organohydrogenpolysiloxane having at least three silicon-bonded hydrogen atoms per molecule; (D) a polyether having at least one aliphatic unsaturated group per molecule; and (E) a hydrosilylation catalyst.

Abstract: The present disclosure proposes an intelligent road side unit and a regulation method thereof. The intelligent road side unit comprises: traffic lights; a first camera configured to acquire a first image and having a first focal length; a second camera configured to acquire a second image and having a second focal length, the first focal length being greater than the second focal length; and a controller, configured to acquire anticipated arriving traffic flow information according to the first image, to acquire current traffic flow information according to the second image, and to control the traffic lights according to the anticipated arriving traffic flow information and the current traffic flow information.

Abstract: Provided are full human anti-PD-L1 antibodies or fragments thereof. In various examples, the antibodies or fragments thereof include a VH CDR1, a VH CDR2, a VH CDR3, a VL CDR1, a VL CDR2, and a VL CDR3 which are selected from sequence groups of SEQ ID NO: 35-42, SEQ ID NO: 43-51, SEQ ID NO: 52-66, SEQ ID NO: 67-79, SEQ ID NO:80-88 and SEQ ID NO: 89-102, respectively, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.